1430 - Assessing measurable residual disease (MRD) by cell-free DNA (cfDNA): results from a real-world series

Primary Author / Presenter(s)

Miguel Arguello-Tomas, MD, MSc

CLINICAL HEMATOLOGIST
Hospital de la Santa Creu i Sant Pau
Barcelona, Catalonia, Spain
EL

Elionor Lynton-Pons, MD

Hospital de la Santa Creu i Sant Pau
Barcelona, Catalonia, Spain
AM

Alba Mora, PhD

Sant Pau Institute for Biomedical Research
Barcelona, Spain
MB

María Laura Blanco, MD

Haematologist
Hospital de la Santa Creu i Sant Pau
Barcelona, Catalonia, Spain
MC

Maria Cerdà, MD

Institut Català d'Oncologia-Hospital Universitari Doctor Josep Trueta de Girona
Girona, Catalonia, Spain
JR

Josep Maria Roncero, MD

Institut Català d'Oncologia-Hospital Universitari Doctor Josep Trueta de Girona
Girona, Catalonia, Spain
EG

Eva Gimeno Vázquez, MD

Department of Hematology, Hospital del Mar
Barcelona, Catalonia, Spain
LG

Lucía Gómez-Pérez, MD

Hospital del Mar
Barcelona, Catalonia, Spain
JN

Josep Nomdedéu, MD, PhD

Head of Hematology Laboratory
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
EM

Esther Moga, MD, PhD

Immunologist
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
CM

Carol Moreno, MD, PhD

Hospital de la Santa Creu i Sant Pau
Barcelona, Spain